Pulmonary Hypertension in Parenchymal Lung Disease

Research output: Contribution to journalReview articlepeer-review

10 Scopus citations


The pathophysiology of pulmonary hypertension (PH) in parenchymal lung diseases is partially related to hypoxic pulmonary vasoconstriction. PH treatment is controversial for these patients. This article focuses on group III PH, namely PH attributable to lung diseases and/or hypoxia. Group III includes chronic obstructive pulmonary disease and interstitial lung diseases, the most common parenchymal lung diseases associated with PH. It also includes sleep-disordered breathing and hypoventilation from any cause. Other parenchymal lung diseases associated with PH, namely sarcoidosis and systemic vasculitides (group V), are discussed. The data describing PH in specific parenchymal diseases are reviewed.

Original languageEnglish (US)
Pages (from-to)461-474
Number of pages14
JournalHeart Failure Clinics
Issue number3
StatePublished - Jul 2012


  • Chronic obstructive pulmonary disease
  • Idiopathic pulmonary fibrosis
  • Interstitial lung disease
  • Pulmonary hypertension

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Pulmonary Hypertension in Parenchymal Lung Disease'. Together they form a unique fingerprint.

Cite this